Lake Street Capital Markets Reiterates Buy Rating on InspireMD (NSPR) Feb 24, 2026 08:55AM
Maxim Group Starts InspireMD (NSPR) at Buy Feb 2, 2026 07:42AM
InspireMD (NSPR) Tops Q3 EPS by 8c Nov 4, 2025 07:30AM
InspireMD (NSPR) Misses Q2 EPS by 5c Aug 5, 2025 09:24AM
InspireMD raises $58 million through equity placement and warrant exercise Jul 31, 2025 08:32AM


Jul 9, 2025 07:01AM InspireMD launches CGuard Prime carotid stent system in US market
Jun 24, 2025 04:06PM InspireMD (NSPR) Announces FDA Approval for CGuard Prime Carotid Stent System for the Prevention of Stroke
Jun 13, 2025 09:00AM InspireMD (NSPR) Announces CE Mark Approval for CGuard Prime Embolic Prevention System (EPS) Under European MDR for the Prevention of Stroke
Jun 13, 2025 08:26AM Piper Sandler Highlights Top Medtech Picks and Catalyst-Rich Names
Jun 3, 2025 04:07PM InspireMD (NSPR) names Michael Lawless CFO
May 12, 2025 08:00AM InspireMD (NSPR) PT Lowered to $4 but Piper Sandler Sees 'Opportunity for Significant Value Creation'
May 9, 2025 07:20AM InspireMD (NSPR) Tops Q1 EPS by 9c
Apr 1, 2025 04:44PM InspireMD (NSPR) Files $200M Mixed Shelf
Mar 12, 2025 07:13AM InspireMD (NSPR) Tops Q4 EPS by 1c
Dec 12, 2024 07:00AM InspireMD (NSPR) Announces CFO Change
Nov 25, 2024 04:06PM InspireMD (NSPR)Appoints Scott R. Ward to its Board
Nov 12, 2024 07:06AM InspireMD (NSPR) Tops Q3 EPS by 4c
Oct 7, 2024 07:04AM InspireMD (NSPR) Announces Approval of IDE Application for CGUARDIANS II Pivotal Study of the CGuard Prime 80cm Carotid Stent System
Sep 17, 2024 07:17AM Piper Sandler Reiterates Overweight Rating on InspireMD (NSPR)
Sep 16, 2024 07:07AM InspireMD (NSPR) Announces Submission of Premarket Approval Application to FDA Seeking U.S. Regulatory Approval of the CGuard™ Prime Carotid Stent System
Aug 6, 2024 08:10AM InspireMD (NSPR) Misses Q2 EPS by 3c